Literature DB >> 33574994

Interventions for the treatment of xerostomia: A randomized controlled clinical trial.

Constanza Marín1, Laura Díaz-de-Valdés1, Catalina Conejeros1, René Martínez1, Sven Niklander1.   

Abstract

BACKGROUND: Xerostomia or dry mouth sensation corresponds to a common clinical problem that can significantly impair the oral health related quality of life (OHRQoL). Currently, there is a large variety of local agents available for the treatment of xerostomia, but there is a lack robust evidence supporting the use of one treatment over another. We aimed to compare the effectiveness of a 1% malic acid salivary stimulant spray with a 1.33% betaine-based saliva substitute mouthwash in the improvement of xerostomia.
MATERIAL AND METHODS: Fifty-one participants with drug induced or idiopathic xerostomia were randomly allocated into three groups, two intervention and one control group (placebo). OHRQoL and severity of xerostomia were assessed with the OHIP-14sp questionnaire and a visual analogue scale (VAS) respectively. Stimulated and non-stimulated salivary flow rates before and after treatments were also measured.
RESULTS: All three groups reported a significantly improvement in the dry mouth sensation and non-stimulated salivary flow rates, but only the malic acid spray and the betaine-based mouthwash significantly improved the OHRQoL. There were no significant differences between both intervention groups.
CONCLUSIONS: This study provides evidence that both tested agents are comparable in improving the dry mouth sensation and OHRQoL of patients with drug induced and idiopathic xerostomia. Key words:Xerostomia, dry mouth, malic acid, betaine, oral-health related quality of life. Copyright:
© 2021 Medicina Oral S.L.

Entities:  

Year:  2021        PMID: 33574994      PMCID: PMC7864369          DOI: 10.4317/jced.57924

Source DB:  PubMed          Journal:  J Clin Exp Dent        ISSN: 1989-5488


  30 in total

Review 1.  Interventions for the management of dry mouth: non-pharmacological interventions.

Authors:  Susan Furness; Gemma Bryan; Roddy McMillan; Helen V Worthington
Journal:  Cochrane Database Syst Rev       Date:  2013-08-30

2.  Risk factors and symptoms associated with xerostomia: a cross-sectional study.

Authors:  A Villa; S Abati
Journal:  Aust Dent J       Date:  2011-09       Impact factor: 2.291

3.  Products based on olive oil, betaine, and xylitol in the post-radiotherapy xerostomia.

Authors:  Margarita Martín; Alicia Marín; Mario López; Olga Liñán; Felipe Alvarenga; David Büchser; Laura Cerezo
Journal:  Rep Pract Oncol Radiother       Date:  2016-11-25

Review 4.  Dry mouth - An overview.

Authors:  Ngo Di Ying Joanna; William Murray Thomson
Journal:  Singapore Dent J       Date:  2015-12

5.  Dry mouth and older people.

Authors:  W M Thomson
Journal:  Aust Dent J       Date:  2015-03       Impact factor: 2.291

6.  Assessing the impact of menopause on salivary flow and xerostomia.

Authors:  E M Minicucci; R B C Pires; R A Vieira; H A Miot; M R Sposto
Journal:  Aust Dent J       Date:  2013-06       Impact factor: 2.291

Review 7.  Xerostomia of Various Etiologies: A Review of the Literature.

Authors:  Marta Tanasiewicz; Tomasz Hildebrandt; Izabela Obersztyn
Journal:  Adv Clin Exp Med       Date:  2016 Jan-Feb       Impact factor: 1.727

8.  The Impact of Hyposalivation on Quality of Life (QoL) and Oral Health in the Aging Population of Al Madinah Al Munawarrah.

Authors:  Mohammad S Ahmad; Ahmed Bhayat; Muhammad Sohail Zafar; Khalid H Al-Samadani
Journal:  Int J Environ Res Public Health       Date:  2017-04-20       Impact factor: 3.390

9.  The diagnostic suitability of a xerostomia questionnaire and the association between xerostomia, hyposalivation and medication use in a group of nursing home residents.

Authors:  Gert-Jan van der Putten; Henk S Brand; Jos M G A Schols; Cees de Baat
Journal:  Clin Oral Investig       Date:  2010-02-18       Impact factor: 3.573

Review 10.  Treatment of xerostomia and hyposalivation in the elderly: A systematic review.

Authors:  J-A Gil-Montoya; F-J Silvestre; R Barrios; J Silvestre-Rangil
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2016-05-01
View more
  3 in total

1.  Efficacy and safety of two artificial saliva-based polymers containing 0.1% pilocarpine for treatment of xerostomia: A randomized clinical pilot trial.

Authors:  Wilairat Sarideechaigul; Aroonsri Priprem; Sucharat Limsitthichaikoon; Pensri Phothipakdee; Rajda Chaijit; Teekayu P Jorns; Nopphakhun Lungruammit; Krittiporn Chaiya
Journal:  J Clin Exp Dent       Date:  2021-10-01

Review 2.  A Review on the Role of Pilocarpine on the Management of Xerostomia and the Importance of the Topical Administration Systems Development.

Authors:  Afroditi Kapourani; Konstantinos N Kontogiannopoulos; Panagiotis Barmpalexis
Journal:  Pharmaceuticals (Basel)       Date:  2022-06-18

3.  Oral Care Recommendation for Cystic Fibrosis Patients-Recommendation for Dentists.

Authors:  Tamara Pawlaczyk-Kamieńska; Maria Borysewicz-Lewicka; Halina Batura-Gabryel; Szczepan Cofta
Journal:  J Clin Med       Date:  2022-05-13       Impact factor: 4.964

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.